CICigna Group

NYSE cigna.com


$ 354.30 $ -0.04 (-0.01 %)    

Friday, 26-Apr-2024 15:59:57 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 354.47
$ 353.69
$ 0.00 x 0
$ 0.00 x 0
$ 351.42 - $ 355.12
$ 236.21 - $ 365.71
830,527
na
103.63B
$ 0.92
$ 20.07
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-05-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 arthritis-patients---cignas-evernorth-to-offer-humira-biosimilar-at-no-out-of-pocket-cost

Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average ...

 cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-384-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $384 price target.

 inconsistent-insurance-coverage-for-weight-loss-drugs---novo-nordisks-glp-1s-face-hurdles-despite-health-benefits

Debate ensues over insurance coverage for Novo Nordisk's Wegovy following FDA approval. Evernorth's EncircleRx introduc...

 cantor-fitzgerald-maintains-overweight-on-cigna-group-raises-price-target-to-384

Cantor Fitzgerald analyst Sarah James maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $37...

 ubs-maintains-buy-on-cigna-group-raises-price-target-to-400

UBS analyst Kevin Caliendo maintains Cigna Group (NYSE:CI) with a Buy and raises the price target from $385 to $400.

 rbc-capital-maintains-outperform-on-cigna-group-raises-price-target-to-383

RBC Capital analyst Ben Hendrix maintains Cigna Group (NYSE:CI) with a Outperform and raises the price target from $354 to $...

 truist-securities-reiterates-buy-on-cigna-group-raises-price-target-to-400

Truist Securities analyst David Macdonald reiterates Cigna Group (NYSE:CI) with a Buy and raises the price target from $380 ...

 broadcom-to-rally-around-21-here-are-10-top-analyst-forecasts-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 mizuho-maintains-buy-on-cigna-group-raises-price-target-to-385

Mizuho analyst Ann Hynes maintains Cigna Group (NYSE:CI) with a Buy and raises the price target from $370 to $385.

 insurance-coverage-for-weight-loss-drugs---cigna-unveils-efforts-to-limit-health-plansemployers-spending

Evernorth Health Services, a Cigna subsidiary, introduces a financial guarantee in its EncircleRx program offering predictabili...

 barclays-initiates-coverage-on-cigna-group-with-overweight-rating-announces-price-target-of-393

Barclays analyst Andrew Mok initiates coverage on Cigna Group (NYSE:CI) with a Overweight rating and announces Price Target ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION